Antiangiogenic therapy of experimental cancer does not induce acquired drug resistance

Boehm, Thomas, Folkman, Judah, Browder, Timothy, O'Reilly, Michael S.·1997·Nature

DOI 10.1038/37126

Cited by (1,002)

Items 801–900 of 1,002

Antiangiogenic Domains Shared by Thrombospondins and Metallospondins, a New Family of Angiogenic Inhibitors
M. Luisa Iruela‐Arispe, Francisca Vázquez, Maria-Asunción Ortega · 1999 · Annals of the New York Academy of Sciences
Epigenetic approach for angiostatic therapy: promising combinations for cancer treatment
Robert H. Berndsen, U. Kulsoom Abdul, Andrea Weiss, Marloes Zoetemelk, Marije T. te Winkel, Paul J. Dyson, Arjan W. Griffioen, Patrycja M. Nowak-Sliwinska · 2017 · Angiogenesis
Multi-input Optimal Control Problems for Combined Tumor Anti-angiogenic and Radiotherapy Treatments
Urszula Ledzewicz, Heinz Schättler · 2011 · Journal of Optimization Theory and Applications
Trans-3,4,5,4′-tetramethoxystilbene, a resveratrol analog, potently inhibits angiogenesis in vitro and in vivo
LiangKe Chen, Pengfei Qiang, Qiping Xu, Yi-hua Zhao, Fang Dai, Lu Zhang · 2013 · Acta Pharmacologica Sinica
Following angiogenin during angiogenesis: a journey from the cell surface to the nucleolus.
Antoni Więdłocha · 1999 · PubMed
Emergence of Taxis and Synergy in Angiogenesis
Barbara Capogrosso-Sansone, Marco Scalerandi, Carlos Alberto Condat · 2001 · Physical Review Letters
Modulation of collagen XVIII/endostatin expression in lobular and biliary rat liver fibrogenesis
Jidong Jia, Michael W Bauer, Nicolai Sedlaczek, Hermann Herbst, Martin Ruehl, Eckhart G. Hahn, Ernst Otto Riecken, Detlef Schuppan · 2001 · Journal of Hepatology
Local Anti-angiogenic Brain Tumor Therapies
Eric P. Sipos, Henry Brem · 2000 · Journal of Neuro-Oncology
Antiangiogenic Therapy in Leukemia
Deborah Ann Thomas, Francis Joseph Giles, Jörge E. Cortes, Maher X. Albitar, Hagop M. Kantarjian · 2001 · Acta Haematologica
Thrombospondin-1 plus irinotecan: a novel antiangiogenic-chemotherapeutic combination that inhibits the growth of advanced human colon tumor xenografts in mice
Paul Calabresi, Giacomo Allegrini, Frederick A. Goulette, James W. Darnowski · 2004 · Cancer Chemotherapy and Pharmacology
Optimizing the Dosing Schedule of TNP-470 [O-(Chloroacetyl-carbamoyl) Fumagillol] Enhances Its Antitumor and Antiangiogenic Efficacies
Satoru Koyanagi, Hiroo Nakagawa, Yukako Kuramoto, Shigehiro Ohdo, Shinji Soeda, Hiroshi Shimeno · 2003 · Journal of Pharmacology and Experimental Therapeutics
Tumor Vasculature Directed Drug Targeting: Applying New Technologies and Knowledge to the Development of Clinically Relevant Therapies
Grietje Molema · 2002 · Pharmaceutical Research
The new tubulin-inhibitor combretastatin A-4 enhances thermal damage in the BT4An rat glioma
Hans Petter Eikesdal, Baard‐Christian Schem, Olav Mella, Olav Dahl · 2000 · International Journal of Radiation Oncology*Biology*Physics
Serum Concentrations of Endostatin in Patients with Vulvar Cancer
Lukas Hefler, Clemens Tempfer, Christian Kainz, Andreas Obermair · 1999 · Gynecologic Oncology
Targeting multiple biological pathways as a strategy to improve the treatment of cancer.
Michael S. O’Reilly · 2002 · PubMed
TXNIP Regulates Natural Killer Cell-Mediated Innate Immunity by Inhibiting IFN-γ Production during Bacterial Infection
Dong Oh Kim, Jae‐Eun Byun, Won Sam Kim, Mi Jeong Kim, Jung Ha Choi, Hanna Kim, Eun‐Ji Choi, Tae‐Don Kim, Suk Ran Yoon, Ji‐Yoon Noh et al. · 2020 · International Journal of Molecular Sciences
The effect of RhoA on human umbilical vein endothelial cell migration and angiogenesis in vitro
Liangping Zhao, Gang Xu, Jianfeng Zhou, Hui Xing, Shixuan Wang, Mingfu Wu, Yun Lu, Ding Ma · 2006 · Oncology Reports
BMS-690514, a VEGFR and EGFR tyrosine kinase inhibitor, shows anti-tumoural activity on non-small-cell lung cancer xenografts and induces sequence-dependent synergistic effect with radiation
Yohann Loriot, Pierre Mordant, Nicolas Dorvault, Thibault De La Motte Rouge, Jean Bourhis, Jean‐Charles Soria, Éric Deutsch · 2010 · British Journal of Cancer
Vascular endothelial growth factor as a survival factor in tumor-associated angiogenesis.
Nesrine I. Affara, Fredika M. Robertson · 2004 · PubMed
Viral nanoparticles decorated with novel EGFL7 ligands enable intravital imaging of tumor neovasculature
Choi‐Fong Cho, Lihai Yu, Tienabe K. Nsiama, Alisha N. Kadam, Arun Raturi, Sourabh Shukla, Giulio A. Amadei, Nicole F. Steinmetz, Leonard G. Luyt, John D. Lewis · 2017 · Nanoscale
3,4-Disubstituted isothiazoles: Novel potent inhibitors of VEGF receptors 1 and 2
Alexander S. Kiselyov, Marina N. Semenova, Victor Vladimirovich Semenov · 2008 · Bioorganic & Medicinal Chemistry Letters
Endothelial endostatin release is induced by general cell stress and modulated by the nitric oxide/cGMP pathway
Martin Hermann Deininger, Wolfgang A. Wybranietz, Florian Graepler, Ulrich M. Lauer, Richard Meyermann, Hermann J. Schluesener · 2003 · The FASEB Journal
Anti‐angiogenic Treatment for Peritoneal Dissemination of Pancreas Adenocarcinoma: A Study Using TNP‐470
Hiroaki Kato, Hiroshi Ishikura, You Kawarada, Mitsuko Furuya, Satoshi Kondo, Hiroyuki Kato, Takashi Yoshiki · 2001 · Japanese Journal of Cancer Research
Diffusion with evolving sources and competing sinks: Development of angiogenesis
Marco Scalerandi, Barbara Capogrosso-Sansone, Carlos Alberto Condat · 2001 · Physical review. E, Statistical physics, plasmas, fluids, and related interdisciplinary topics
Coelectrotransfer to skeletal muscle of three plasmids coding for antiangiogenic factors and regulatory factors of the tetracycline-inducible system: tightly regulated expression, inhibition of transplanted tumor growth, and antimetastatic effect
Dominique Martel-Renoir, Véronique Trochon-Joseph, Ariane Galaup, Céline Bouquet, Frank Griscelli, Paule Opolon, David Opolon, Elisabeth Connault, Lluis M. Mir, Michel Perricaudet · 2003 · Molecular Therapy
Intramuscular delivery of antiangiogenic genes suppresses secondary metastases after removal of primary tumors
Xueying Sun, Haiquan Qiao, Hongchi Jiang, Xu–Ting Zhi, Fengjun Liu, Jianli Wang, Meng Liu, Dianning Dong, Jagat R. Kanwar, Ruian Xu et al. · 2004 · Cancer Gene Therapy
Therapeutic targeting of the tumor vasculature
Gillian M. Tozer, Roy Bicknell · 2004 · Seminars in Radiation Oncology
Low Dose Carboplatin Combined With Angiostatic Agents Prevents Metastasis in Human Testicular Germ Cell Tumor Xenografts
DIETMAR ABRAHAM, SAMAD ABRI, Michael Hofmann, WOLFGANG HÖLTL, Seyedhossein Aharinejad · 2003 · The Journal of Urology
Generation of a high titre retroviral vector for endothelial cell-specific gene expression in vivo
Georgia Mavria, U Jäger, C D Porter · 2000 · Gene Therapy
Antiangiogenic gene therapy
K K W Lau, Roy Bicknell · 1999 · Gene Therapy
Vascular endothelial growth factor receptors and the therapeutic targeting of angiogenesis in cancer: where do we go from here?
David J. Bruce, Peng Tan · 2011 · Cell Communication & Adhesion
An analysis of the factors that affect the dissociation of inclusion bodies and the refolding of endostatin under high pressure
Rosa Maria Chura‐Chambi, Yraima Cordeiro, N.V. Malavasi, L.S. Lemke, Daniella Rodrigues, Lígia Morganti · 2013 · Process Biochemistry
Characterization and functional elucidation of a fucosylated 1,6-α-d-mannogalactan polysaccharide from Antrodia cinnamomea
Jing‐Jy Cheng, Mei‐Kuang Lu, Cha-Yui Lin, Chia-Chuan Chang · 2010 · Carbohydrate Polymers
Effects of lycopene and apigenin on human umbilical vein endothelial cells in vitro under angiogenic stimulation
Mehmet Ali Sahin, Emel Şahın, Saadet Gümüşlü · 2011 · Acta Histochemica
Treatment of experimental breast cancer using interleukin-12 gene therapy combined with anti–vascular endothelial growth factor receptor-2 antibody
Alexander L. Rakhmilevich, Andrea T. Hooper, Daniel J. Hicklin, Paul M. Sondel · 2004 · Molecular Cancer Therapeutics
Inhibition of vascular endothelial growth factor-induced angiogenesis by chlorogenic acid via targeting the vascular endothelial growth factor receptor 2-mediated signaling pathway
Shaoling Lin, Jiamiao Hu, Xuelin Zhou, Peter Chi Keung Cheung · 2017 · Journal of Functional Foods
The Challenges of Recombinant Endostatin in Clinical Application: Focus on the Different Expression Systems and Molecular Bioengineering
Abbas Mohajeri, Sarvin Sanaei, Farhad Kiafar, Amir Fattahi, Majid Khalili, Nosratollah Zarghami · 2017 · Advanced Pharmaceutical Bulletin
Angiostatin prolongs the survival of mice with leptomeningeal metastases
Jaap C. Reijneveld, MARTIN J.B. TAPHOORN, O. A. J. Kerckhaert, T A Drixler, Willem J. Boogerd, Emile E. Voest · 2003 · European Journal of Clinical Investigation
New Molecular Mechanisms of Duodenal Ulceration
Sándor Szabó, Xiaoming Deng, Tetyana Khomenko, Longchuan Chen, Ganna M. Tolstanova, Klára Ősapay, Zsuzsanna Sandor, Ximing Xiong · 2007 · Annals of the New York Academy of Sciences
Targeting Angiogenic Pathways Involving Tumor–stromal Interaction to Treat Advanced Human Prostate Cancer
Mitchell H. Sokoloff, Leland W.K. Chung · 1998 · Cancer and Metastasis Reviews
Pancreatic tumor growth is regulated by the balance between positive and negative modulators of angiogenesis
Gunter Schuch, Oliver Kisker, Anthony Atala, Shay Söker · 2002 · Angiogenesis
Angiogenesis as a target for cancer therapy
Kerim Kaban, Roy S. Herbst · 2002 · Hematology/Oncology Clinics of North America
Concise stereocontrolled routes to fumagillol, fumagillin, and TNP‐470
David A. Vosburg, Sven Weiler, Erik J. Sorensen · 2003 · Chirality
Phase I/II clinical study of pulsed paclitaxel radiosensitization for thoracic malignancy: a therapeutic approach on the basis of preclinical research of human cancer cell lines.
Yuhchyau Chen, Kishan J. Pandya, Peter C. Keng, David W. Johnstone, Jigang Li, Yi‐Jang Lee, T. Smudzin, Paul Okunieff · 2003 · PubMed
Increased expression of collagen XVIII and its prognostic value in nonsmall cell lung carcinoma
Hao Chang, Toshihiko Iizasa, Kiyoshi Shibuya, Akira Iyoda, Makoto Suzuki, Yasumitsu Moriya, Tian‐Ling Liu, Takaki Hiwasa, Kenzo Hiroshima, Takehiko Fujisawa · 2004 · Cancer
Regulating Angiogenesis: A New Therapeutic Strategy
Milo Gibaldi · 1998 · The Journal of Clinical Pharmacology
Clinical evaluation of biologically targeted drugs: Obstacles and opportunities
Anthony L. Boral, Scott K. Dessain, Bruce Allan Chabner · 1998 · Cancer Chemotherapy and Pharmacology
Singular controls and chattering arcs in optimal control problems arising in biomedicine
Urszula Ledzewicz, Heinz Schättler · 2009 · Control and Cybernetics
Endocrine gland‐derived vascular endothelial growth factor (EG‐VEGF) expression in colorectal cancer
Hideki Nagano, Takanori Goi, Kenji Koneri, Yasuo Hirono, Kanji Katayama, Akio Yamaguchi · 2007 · Journal of Surgical Oncology
Liposomes modified with YIGSR peptide for tumor targeting
Praveen Kumar Dubey, Deepak Singodia, Suresh Prasad Vyas · 2009 · Journal of drug targeting
Inhibition of Vasculogenic Mimicry and Angiogenesis by an Anti-EGFR IgG1-Human Endostatin-P125A Fusion Protein Reduces Triple Negative Breast Cancer Metastases
Seung-Uon Shin, Hyun-Mi Cho, Rathin Das, Hava Gil-Henn, Sundaram Ramakrishnan, Ahmed Al Bayati, Stephen F. Carroll, Yu Zhang, Ankita P. Sankar, Christian Elledge et al. · 2021 · Cells
Pharmacological aspects of targeting cancer gene therapy to endothelial cells
H.H. Sedlacek · 2001 · Critical Reviews in Oncology/Hematology
The N-Terminal Integrity Is Critical for the Stability and Biological Functions of Endostatin
Yan Fu, Yongzhang Luo · 2010 · Biochemistry
From total empiricism to a rational design of metronomic chemotherapy phase I dosing trials
Thomas Lam, Hetherington Jw, John Greenman, Anthony Maraveyas · 2006 · Anti-Cancer Drugs
Evaluation of combretastatin A-4 prodrug in a non-Hodgkin’s lymphoma xenograft model: preclinical efficacy
Sanaa M. Nabha, Ramzi M. Mohammad, Nathan R. Wall, Julie A. Dutcher, Bashar M Salkini, George R. Pettit, Ayad M Al-Katib · 2001 · Anti-Cancer Drugs
Role of Angiogenesis in the Progression and Treatment of Prostate Cancer
Margaret Choy, Shahin Rafii, Shahin Raffii · 2001 · Cancer Investigation
The Id proteins: targets for inhibiting tumor cells and their blood supply
Robert Benezra · 2001 · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer
Serum endostatin levels in patients with hepatocellular carcinoma
M Yamagata, Yoshimune Shiratori, Yoshiyuki Dan, Shuichiro Shiina, Tatsuya Takayama, Masatoshi Makuuchi, Masao Omata · 2000 · Annals of Oncology
Hydrodynamics-based gene delivery of naked DNA encoding fetal liver kinase-1 gene effectively suppresses the growth of pre-existing tumors
H Yazawa, T Murakami, HM Li, Timothy Carrel Back, K Kurosaka, Y Suzuki, Lynnete Shorts, Yasuto Akiyama, Kouji Maruyama, Erin M. Parsoneault et al. · 2006 · Cancer Gene Therapy
Expression of human apolipoprotein(a) kringles in colon cancer cells suppresses angiogenesis‐dependent tumor growth and peritoneal dissemination
Hyun-Kyung Yu, Jin‐Hyung Ahn, Ho‐Jeong Lee, Suk‐Keun Lee, Soon Won Hong, Yeup Yoon, Jang‐Seong Kim · 2004 · The Journal of Gene Medicine
Contributions of Disulfide Bonds in a Nested Pattern to the Structure, Stability, and Biological Functions of Endostatin
Hao Zhou, Wei Wang, Yongzhang Luo · 2005 · Journal of Biological Chemistry
Neomycin Inhibits the Angiogenic Activity of Fibroblast and Epidermal Growth Factors
Guo‐fu Hu · 2001 · Biochemical and Biophysical Research Communications
In vitro and in vivo effects of an anti-mouse endoglin (CD105)–immunotoxin on the early stages of mouse B16MEL4A5 melanoma tumours
Raquel Muñoz, Yolanda Arias, José Miguel Ferreras, Pilar Jiménez, Carmen Langa, Maria Angeles Rojo, Manuel José Gayoso, Damián Córdoba-Díaz, Carmelo Bernabéu, Tomás Girbés · 2012 · Cancer Immunology Immunotherapy
Novel human Ab against vascular endothelial growth factor receptor 2 shows therapeutic potential for leukemia and prostate cancer
Ruei‐Min Lu, Chiung‐Yi Chiu, I.-Ju Liu, Yu‐Ling Chang, Yaw‐Jen Liu, Han‐Chung Wu · 2019 · Cancer Science
The disintegrin contortrostatin in combination with docetaxel is a potent inhibitor of prostate cancer in vitro and in vivo
Edwin Lin, Qingcai Wang, Stephen D. Swenson, Hossein Jadvar, Susan G. Groshen, Wei Ye, Francis S. Markland, Jacek Pinski · 2010 · The Prostate
Epigenetic modulators mitigate angiogenesis through a complex transcriptomic network
Thammadihalli Veerasangaiah Shiva Shankar, Luc Willems · 2014 · Vascular Pharmacology
Endostatin gene variation and protein levels in breast cancer susceptibility and severity
Sabapathy Prakash Balasubramanian, Simon S. Cross, Jenny Globe, Angela Cox, Nicola Jane Brown, Malcolm Reed · 2007 · BMC Cancer
Apoptosis, Angiogenesis and Cancer Therapies
Manjul Tiwari · 2012 · journal of cancer therapeutics and research
Glioblastoma Multiforme and Adult Neurogenesis in the Ventricular‐Subventricular Zone: A Review
Claudia Capdevila, Lucía Rodríguez‐Vázquez, Joaquı́n Martı́ · 2016 · Journal of Cellular Physiology
The extracellular matrix: a new turn-of-the-screw for anti-angiogenic strategies
Laura Sanz, Luis Álvarez‐Vallina · 2003 · Trends in Molecular Medicine
Endostatin influences endothelial morphology via the activated ERK1/2-kinase endothelial morphology and signal transduction
Annette Schmidt, Daniela Wenzel, Irmgard S. Thorey, Takako Sasaki, Jürgen Hescheler, Rupert Timpl, Klaus Addicks, Sabine Werner, Bernd K. Fleischmann, Wilhelm Bloch · 2006 · Microvascular Research
Clinical relevance of maspin expression in bladder cancer
Wolf-D. Beecken, Tobias Engl, Knut Engels, Christa Blumenberg, Elsie Oppermann, Kevin A. Camphausen, Yuen Shing, G. Reinecke, Dietger Jonas, Roman Alexander Blaheta · 2006 · World Journal of Urology
Identification of differentially expressed proteins in human malignant pleural effusions
W-Y. Hsieh, M.-J. Chen, H-T. Ho, T-M. You, Y-T. Lu · 2006 · European Respiratory Journal
The use of bispecific antibodies in tumor cell and tumor vasculature directed immunotherapy
Grietje Molema, Bart Jan Kroesen, Wijnand Helfrich, Dirk K. F. Meijer, Lou F. M. H. de Leij · 2000 · Journal of Controlled Release
Prospects for the treatment of endocrine-responsive tumours.
Stephen Green, B.J.A. Furr · 1999 · Endocrine Related Cancer
Antiangiogenesis, Anti-VEGF(R) and Outlook
Iver Petersen · 2007 · Springer eBooks
Anti-angiogenic activity of human endostatin is HIF-1-independent in vitro and sensitive to timing of treatment in a human saphenous vein assay.
Gordon R. Macpherson, Sylvia S. W. Ng, Siiri L. Forbes, Giovanni Melillo, Tatiana Karpova, James G. McNally, Thomas P. Conrads, Timothy D. Veenstra, Alfredo Martı́nez, Frank F. Cuttitta et al. · 2003 · PubMed
Endostatin gene therapy on murine lung metastases model utilizing cationic vector-mediated intravenous gene delivery
Yoshiaki Nakashima, Motoki Yano, Yasunobu Kobayashi, S. Moriyama, H Sasaki, Tatsuya Toyama, Hiroshi Yamashita, Ichiro Fukai, Hirotaka Iwase, Yosuke Yamakawa et al. · 2003 · Gene Therapy
Effect of Thalidomide in Hepatocellular Carcinoma: Assessment with Power Doppler US and Analysis of Circulating Angiogenic Factors
Chiun Hsu, Chiung‐Nien Chen, Li‐Tzong Chen, Chen-Yao Wu, Fon‐Jou Hsieh, Ann‐Lii Cheng · 2005 · Radiology
Gene therapy for malignant liver disease
Leonhard Mohr, Michael Geißler, Hubert Erich Blum · 2002 · Expert Opinion on Biological Therapy
Efficacy of antiangiogenic therapy with TNP-470 in superficial and invasive bladder cancer models in mice
Wolf-Dietrich C. Beecken, Antonio Fernandez, Dipak Panigrahy, Eike‐Gert Achilles, Oliver Kisker, Evelyn A. Flynn, Antonia Maria Joussen, Judah Folkman, Yuen Shing · 2000 · Urology
Extracellular Protein Fibulin-7 and Its C-Terminal Fragment Have In Vivo Antiangiogenic Activity
Tomoko Ikeuchi, Susana de Vega, Patricia Forcinito, Andrew D. Doyle, Juan Amaral, Ignacio R. Rodríguez, Eri Arikawa‐Hirasawa, Yoshihiko Yamada · 2018 · Scientific Reports
Deficiency of Disulfide Bonds Facilitating Fibrillogenesis of Endostatin
Yingbo He, Hao Zhou, Huadong Tang, Yongzhang Luo · 2005 · Journal of Biological Chemistry
Endostatin plus interferon-α2b therapy for metastatic melanoma: a novel combination of antiangiogenic and immunomodulatory agents
Stergios J. Moschos, Christine Odoux, Stephanie R. Land, Sanjiv S. Agarwala, David Friedland, K Völker, Carolyn Fowler Sidor, Michael K.K. Wong, John M. Kirkwood · 2007 · Melanoma Research
Dual Targeting of Tumor Angiogenesis and Chemotherapy by Endostatin–Cytosine Deaminase–Uracil Phosphoribosyltransferase
Chun‐Te Chen, Hirohito Yamaguchi, Hong-Jen Lee, Yi Du, Heng‐Huan Lee, Weiya Xia, Wen-Hsuan Yu, Jennifer L. Hsu, Chia-Jui Yen, Hui‐Lung Sun et al. · 2011 · Molecular Cancer Therapeutics
Endoscopy-guided orthotopic implantation of colorectal cancer cells results in metastatic colorectal cancer in mice
Dominik Bettenworth, Marcus Maximilian Mücke, Katrin Schwegmann, Andreas Faust, Christopher Poremba, Michael Andreas Schäfers, Dirk Domagk, Philipp Lenz · 2016 · Clinical & Experimental Metastasis
Gene Transfer of Pigment Epithelium-Derived Factor Suppresses Tumor Growth and Angiogenesis in a Hepatoblastoma Xenograft Model
Marybeth Browne, Veronica M. Stellmach, Mona L. Cornwell, Chuhan Chung, Jennifer A. Doll, Eun Jig Lee, J. Larry Jameson, Marleta Reynolds, Riccardo Antonio Superina, Lisa P. Abramson et al. · 2006 · Pediatric Research
Endostatin gene therapy enhances the efficacy of IL-2 in suppressing metastatic renal cell carcinoma in mice
Flávia Gomes de Góes Rocha, Karen Cristina Barbosa Chaves, Roger J. Chammas, Jean Pierre Schatzmann Peron, Luiz Vicente Rizzo, Nestor Schor, Maria Helena Bellini · 2010 · Cancer Immunology Immunotherapy
The therapeutic potential of novel antiangiogenic therapies
Frank A. Scappaticci · 2003 · Expert Opinion on Investigational Drugs
Inhibition of angiogenesis in cancer patients
Henk M.W. Verheul, Herbert M. Pinedo · 2005 · Expert Opinion on Emerging Drugs
Type I collagen gene suppresses tumor growth and invasion of malignant human glioma cells
Kimi Honma, Teruo Miyata, Takahiro Ochiya · 2007 · Cancer Cell International
Microvascular density and vascular endothelial growth factor immunoreactivity as predictors of regional lymph node metastasis from betel-associated oral squamous cell carcinoma
Yong‐Kie Wong, Chung‐Ji Liu, Po‐Cheung Kwan, Shou‐Yee Chao · 2003 · Journal of Oral and Maxillofacial Surgery
Do antiangiogenic protein fragments have amyloid properties?
Martijn F.B.G. Gebbink, Emile E. Voest, Arie Reijerkerk · 2004 · Blood
Concurrent delivery of GM‐CSF and endostatin genes by a single adenoviral vector provides a synergistic effect on the treatment of orthotopic liver tumors
Kuo‐Feng Tai, Pei‐Jer Chen, Ding‐Shinn Chen, Lih‐Hwa Hwang · 2003 · The Journal of Gene Medicine
In vivo Generation of Angiostatin Isoforms by Administration of a Plasminogen Activator and a Free Sulfhydryl Donor: A Phase I Study of an Angiostatic Cocktail of Tissue Plasminogen Activator and Mesna
Gerald A. Soff, Hao Wang, Deborah L. Cundiff, Keyi Jiang, Brenda K. Martone, ALFRED W. RADEMAKER, Jennifer A. Doll, Timothy Michael Kuzel · 2005 · Clinical Cancer Research
YM-359445, an Orally Bioavailable Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor, Has Highly Potent Antitumor Activity against Established Tumors
Nobuaki Amino, Yukitaka Ideyama, Mayumi Yamano, Sadao Kuromitsu, Katsuinori Tajinda, Kiyohiro Samizu, Hiroyuki Hisamichi, Akira Matsuhisa, Kenna Shirasuna, Masafumi Kudoh et al. · 2006 · Clinical Cancer Research
Effect of oralLactococcus lactiscontaining endostatin on 1, 2-dimethylhydrazine-induced colon tumor in rats
Wei Li · 2005 · World Journal of Gastroenterology
KAPOSI'S SARCOMA
Pere Gascón, Robert Allen Schwartz · 2000 · Dermatologic Clinics
Increased γ-H2AX and Rad51 DNA Repair Biomarker Expression in Human Cell Lines Resistant to the Chemotherapeutic Agents Nitrogen Mustard and Cisplatin
Sheba Adam Zahir, Piers Nicholas Plowman, Emma C. Bourton, Fariha Sharif, Christopher N. Parris · 2014 · Chemotherapy
TEM8 Tri-specific Killer Engager binds both tumor and tumor stroma to specifically engage natural killer cell anti-tumor activity
Michal Filip Kaminski, Laura E. Bendzick, Rachel Hopps, Marissa Kauffman, Behiye Kodal, Yvette Soignier, Peter Hinderlie, Joshua T. Walker, Todd R. Lenvik, Melissa Ann Geller et al. · 2022 · Journal for ImmunoTherapy of Cancer